AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
+38.55%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.94B
AUM Growth
+$2.94B
Cap. Flow
-$16M
Cap. Flow %
-0.55%
Top 10 Hldgs %
47.94%
Holding
134
New
28
Increased
21
Reduced
57
Closed
5

Sector Composition

1 Healthcare 75.63%
2 Consumer Discretionary 16.28%
3 Technology 3.84%
4 Financials 1.19%
5 Communication Services 0.95%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MEIP icon
101
MEI Pharma
MEIP
$160M
$2.95M 0.08% +714,000 New +$2.95M
NERV icon
102
Minerva Neurosciences
NERV
$16.5M
$2.89M 0.08% 800,000 -200,000 -20% -$722K
CYRX icon
103
CryoPort
CYRX
$444M
$2.69M 0.08% +89,000 New +$2.69M
PTGX icon
104
Protagonist Therapeutics
PTGX
$3.67B
$2.47M 0.07% +140,000 New +$2.47M
ORTX
105
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$2.22M 0.06% 370,000 -30,000 -8% -$180K
KDNY
106
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$2.2M 0.06% 950,000 -50,000 -5% -$116K
ACET icon
107
Adicet Bio
ACET
$59.9M
$2.05M 0.06% +953,000 New +$2.05M
CRIS icon
108
Curis
CRIS
$20.9M
$1.79M 0.05% 1,478,662 -21,338 -1% -$25.8K
VXRT
109
DELISTED
Vaxart
VXRT
$1.77M 0.05% +200,000 New +$1.77M
CTMX icon
110
CytomX Therapeutics
CTMX
$336M
$1.57M 0.04% +188,000 New +$1.57M
BLU
111
DELISTED
BELLUS Health Inc.
BLU
$1.48M 0.04% +143,763 New +$1.48M
IRWD icon
112
Ironwood Pharmaceuticals
IRWD
$214M
$1.14M 0.03% 110,532
CDTX icon
113
Cidara Therapeutics
CDTX
$1.66B
$873K 0.02% +236,500 New +$873K
RIGL icon
114
Rigel Pharmaceuticals
RIGL
$697M
$619K 0.02% 338,000 -12,000 -3% -$22K
ABBV icon
115
AbbVie
ABBV
$372B
0
ARWR icon
116
Arrowhead Research
ARWR
$3.05B
-600,000 Closed -$17.3M
BAC icon
117
Bank of America
BAC
$376B
0
BLUE
118
DELISTED
bluebird bio
BLUE
-100,000 Closed -$4.6M
BMRN icon
119
BioMarin Pharmaceuticals
BMRN
$11.2B
0
C icon
120
Citigroup
C
$178B
0
DAL icon
121
Delta Air Lines
DAL
$40.3B
0
GM icon
122
General Motors
GM
$55.8B
0
GS icon
123
Goldman Sachs
GS
$226B
0
JPM icon
124
JPMorgan Chase
JPM
$829B
0
MA icon
125
Mastercard
MA
$538B
0